Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial

NCT03844048 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT03844048
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03844048 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
Lead sponsor
AbbVie
Phase
Phase 3
Overall status
Active, not recruiting
Start date
September 6, 2019
Completion date
August 31, 2027
Enrollment
165 (actual)
Sites
56

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia, acute myeloid leukemia, cancer, chronic lymphocytic leukemia, multiple myeloma, non-hodgkin's lymphoma